Company News 20 Nov 2025 Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum Momentum is growing for Remplir™ in nerve-sparing prostate cancer surgery, with around 100 surgeries now performed using the flagship nerve repair device. Orthocell
Company News 05 Nov 2025 Orthocell Appoints Second Canadian Distributor for Remplirâ„¢ Orthocell has appointed its second distributor in Canada. The appointment completes national coverage across the US$75 million Canadian market, ensuring… Orthocell
Company News 03 Nov 2025 First Remplirâ„¢ Surgical Case Completed in Hong Kong Orthocell has announced the successful completion of the first Remplirâ„¢ surgical case in Hong Kong and the official launch of… Orthocell
